Xue Tao,Sun Yunchuan,Liu Guangbo.Dosimetric impacts of Utrecht applicator on three-dimensional brachytherapy for advanced cervical carcinoma[J].Chinese Journal of Radiological Medicine and Protection,2019,39(11):837-840
Dosimetric impacts of Utrecht applicator on three-dimensional brachytherapy for advanced cervical carcinoma
Received:April 15, 2019  
DOI:10.3760/cma.j.issn.0254-5098.2019.11.007
KeyWords:Cervical cancer  Brachytherapy  Utrecht applicator  Dosimetry
FundProject:
Author NameAffiliationE-mail
Xue Tao Department of Radiotherapy and Chemotherapy, Cangzhou Integrated Traditional Chinese and Western Medicine Hospital, Cangzhou 061000, China  
Sun Yunchuan Department of Radiotherapy and Chemotherapy, Cangzhou Integrated Traditional Chinese and Western Medicine Hospital, Cangzhou 061000, China 13932719095@163.com 
Liu Guangbo Department of Radiotherapy and Chemotherapy, Cangzhou Integrated Traditional Chinese and Western Medicine Hospital, Cangzhou 061000, China  
Hits: 4304
Download times: 1687
Abstract::
      Objective To investigate the effect of Utrecht applicator on dosimetrics of targets and OARs in brachytherapy for advanced cervical cancer. Methods Data of patients with locally advanced cervical cancer who received brachytherapy with Utrecht Source Applicator from 2017 to 2018 in the Department of Radiotherapy, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Hebei province, were collected. The original plan was intracavitary/interstitial brachytherapy (IC/IS-BT). With the original contour and prescription dose unchanged, the implantation was removed and new intracavitary brachytherapy (IC) plan was designed. The dosimetric parameters of IC/IS plan and IC plan were compared and analyzed, and the effect of IS implantation on dose was evaluated. Results The D90 of HR-CTV was (88.68±1.84) Gy in IC/IS group and (85.54±0.54) Gy in IC group, with significant difference(t=6.200,P<0.05). In addition, conformity index of the IC/IS plan was significantly higher than that of the IC plan (IC/IS:0.58±0.08, IC:0.43±0.05;t=1.010, P<0.05).In terms of OAR, there was no significant difference in dosage between the two groups (P>0.05). Conclusions For the brachytherapy of locally advanced cervical cancer, the use of Utrecht Source Applicator can satisfy the prescription dose coverage. Adding IS insertion needle can improve the optimization space of the plan. Without exceeding the dose limit of OAR, the radiation dose to HR-CTV can be significantly increased, and the uniformity of dose distribution can be improved as well.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:12034892  On-line:0

v
Scan QR Code
&et=8400690B225D0A4494B405B0EF9D9C895419CF05D61C2E67AF6FA9DC7CAB2361C1572C73A511B702F38804567A3F7D22C08DE59520D969AEE0CCBC44CB4D633495E496F7DAFAA52ABA9A1CFA76B3A05C447921D17B14CFD9BC193BB54D984CF8DF91682EAF6A16AE75B2EDF1D1FD4601&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=B6351343F4791CA3&aid=7BA62EAAEF4CF3CA5E47CF7E6A69D7B9&vid=&iid=708DD6B15D2464E8&sid=2C8B50BA95995EA2&eid=F7B726EE3ACCF328&fileno=20191107&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="B6351343F4791CA3"; var my_aid="7BA62EAAEF4CF3CA5E47CF7E6A69D7B9";